Penicillamine

AAGYLUR, Cuprimine, Depen

Antirheumatic Agent

NADAC/unit N/A

No Shortage Tier 1: 19.8% PA Req: 31.0% 8 Manufacturers 9 ANDAs

Covered Lives

Market Intelligence

2023-12-20 Class II Recall: Lupin Pharmaceuticals Inc.

Generic Manufacturers

BRECKENRIDGE PHARMACEUTICAL INCDR REDDYS LABORATORIES LTDGRANULES PHARMACEUTICALS INCINVAGEN PHARMACEUTICALS INCLUPIN LTDMYLAN SPECIALTY LPNAVINTA LLCPH HEALTH LTDVALEANT PHARMACEUTICALS INTERNATIONALWATSON LABORATORIES INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Penicillamine drfinder.aiFind doctors who prescribe Penicillamine rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Penicillamine

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.